Delivery technologies for cancer immunotherapy.
Riley RS, June CH, Langer R, Mitchell MJ.
Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z.
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications.
Zhang Y, Zhang Z.
Cell Mol Immunol. 2020 Aug;17(8):807-821. doi: 10.1038/s41423-020-0488-6. Epub 2020 Jul 1.
Cancer and the Immune System: The History and Background of Immunotherapy.
Abbott M, Ustoyev Y.
Semin Oncol Nurs. 2019 Oct;35(5):150923. doi: 10.1016/j.soncn.2019.08.002. Epub 2019 Sep 13.
Integrative Approaches to Cancer Immunotherapy.
Szeto GL, Finley SD.
Trends Cancer. 2019 Jul;5(7):400-410. doi: 10.1016/j.trecan.2019.05.010.
A review of cancer immunotherapy toxicity.
Kennedy LB, Salama AKS.
CA Cancer J Clin. 2020 Mar;70(2):86-104. doi: 10.3322/caac.21596. Epub 2020 Jan 16.
Immunotherapy: a promising approach for glioma treatment.
Yasinjan F, Xing Y, Geng H, Guo R, Yang L, Liu Z, Wang H.
Front Immunol. 2023 Sep 7;14:1255611. doi: 10.3389/fimmu.2023.1255611. eCollection 2023.
Dynamics and specificities of T cells in cancer immunotherapy.
Oliveira G, Wu CJ.
Nat Rev Cancer. 2023 May;23(5):295-316. doi: 10.1038/s41568-023-00560-y. Epub 2023 Apr 12.
Corticosteroids and Cancer Immunotherapy.
Goodman RS, Johnson DB, Balko JM.
Clin Cancer Res. 2023 Jul 14;29(14):2580-2587. doi: 10.1158/1078-0432.CCR-22-3181.
Cancer immunoediting and resistance to T cell-based immunotherapy.
O'Donnell JS, Teng MWL, Smyth MJ.
Nat Rev Clin Oncol. 2019 Mar;16(3):151-167. doi: 10.1038/s41571-018-0142-8.
Utilizing chemokines in cancer immunotherapy.
Märkl F, Huynh D, Endres S, Kobold S.
Trends Cancer. 2022 Aug;8(8):670-682. doi: 10.1016/j.trecan.2022.04.001. Epub 2022 Apr 29.
